News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
589,888 Results
Type
Article (21101)
Company Profile (360)
Press Release (568420)
Multimedia
Podcasts (130)
Webinars (16)
Section
Business (194491)
Career Advice (444)
Deals (29920)
Drug Delivery (74)
Drug Development (71407)
Employer Resources (41)
FDA (12290)
Job Trends (10585)
News (285365)
Policy (22185)
Tag
2025 Best Places to Work (17)
2026 Best Places to Work (26)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (5)
2027 Pharm Country Standard (3)
40 Under 40 (4)
Academia (1273)
Accelerated approval (52)
ADA (39)
Adcomms (16)
Allergies (160)
Alliances (41163)
ALS (246)
Alzheimer's disease (1582)
Antibody-drug conjugate (ADC) (673)
Approvals (13026)
Artificial intelligence (696)
ASCO (274)
Autoimmune disease (457)
Automation (44)
Bankruptcy (305)
Belgium (31)
Best Places to Work (8505)
BIO (67)
Biologics (90)
BIOSECURE Act (7)
Biosimilars (204)
BioSpace Insights (92)
Biotechnology (228)
Bispecific (61)
Bladder cancer (195)
Brain cancer (77)
Breast cancer (762)
Cancer (6424)
Cardiovascular disease (467)
Career advice (390)
Career pathing (16)
CAR-T (378)
CDC (11)
CDMO (143)
Celiac Disease (6)
Cell therapy (1015)
Cervical cancer (50)
Clinical research (64716)
Collaboration (2291)
Commercialization (60)
Company closure (4)
Compensation (1785)
Complete response letters (82)
COVID-19 (1476)
CRISPR (140)
CRO (4)
C-suite (1359)
Cystic fibrosis (152)
Data (9556)
Denatured (30)
Depression (173)
Dermatology (167)
Diabetes (564)
Diagnostics (4971)
Digital health (52)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (406)
Drug pricing (60)
Drug shortages (6)
Duchenne muscular dystrophy (357)
Earnings (81674)
Editorial (39)
Employer branding (6)
Employer resources (39)
ESMO (384)
Events (105468)
Executive appointments (1063)
Eye disease (18)
FDA (16338)
Fibrodysplasia Ossificans Progressiva (15)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (39)
Funding (1858)
Gene editing (285)
Generative AI (53)
Gene therapy (811)
GLP-1 (756)
Government (1789)
Grass and pollen (4)
Guidances (343)
Healthcare (12182)
Hematology (181)
HIV (81)
Huntington's disease (78)
Idiopathic pulmonary fibrosis (11)
IgA nephropathy (130)
Immunology and inflammation (314)
Immuno-oncology (136)
Indications (259)
Infectious disease (1764)
Inflammatory bowel disease (235)
Inflation Reduction Act (12)
Influenza (101)
Intellectual property (345)
Interviews (59)
IPO (14391)
IRA (13)
Job creations (2429)
Job search strategy (345)
JPM (41)
Kidney cancer (23)
Kidney disease (150)
Labor market (46)
Layoffs (321)
Leadership (22)
Legal (5661)
Licensing (121)
Liver cancer (72)
Longevity (46)
Lung cancer (911)
Lung diease (20)
Lymphoma (452)
Machine learning (50)
Management (10)
Manufacturing (1007)
Marketing (35)
MASH (209)
Medical affairs (5)
Medical device (10001)
Medtech (10229)
Melanoma (120)
Mergers & acquisitions (16865)
Metabolic disorders (1403)
Middle East (1)
mRNA (245)
Multiple sclerosis (188)
Multispecific (7)
NASH (14)
Netherlands (20)
Neurodegenerative disease (504)
Neuropsychiatric disorders (114)
Neuroscience (3339)
Neurotech (3)
NextGen: Class of 2026 (4132)
Non-profit (1530)
Now hiring (50)
Obesity (587)
Opinion (174)
Ovarian cancer (262)
Pain (269)
Pancreatic cancer (385)
Parkinson's disease (411)
Partnered (26)
Patents (674)
Patient advocacy (8)
Patient recruitment (846)
Patient selection (103)
Peanut (61)
People (50149)
Peptides (37)
Pharmaceutical (51)
Pharmacy benefit managers (16)
Phase 1 (21372)
Phase 2 (29228)
Phase 3 (19883)
Pipeline (12285)
Policy (126)
Postmarket research (1891)
Preclinical (9126)
Press Release (52)
Prostate cancer (331)
Psychedelics (91)
Radioligand (3)
Radiopharmaceuticals (389)
Rare diseases (1265)
Real estate (3788)
Recruiting (14)
Regenerative medicine (30)
Regulatory (20166)
Reports (43)
Research institute (1352)
Resumes & cover letters (61)
Rett syndrome (58)
RNA editing (38)
RSV (61)
Schizophrenia (194)
Series A (348)
Series B (240)
Series C (1)
Service/supplier (5)
Sickle cell disease (131)
Special edition (24)
Spinal muscular atrophy (149)
Sponsored (25)
Startups (3139)
State (1)
Stem cells (7)
Stomach cancer (10)
Substance use disorders (22)
Supply chain (84)
Switzerland (16)
Tariffs (22)
The Weekly (98)
Vaccines (642)
Venture capital (127)
Weight loss (302)
Wet AMD (6)
Women's health (132)
Women in leadership (1)
Worklife (5)
Date
Today (69)
Last 7 days (561)
Last 30 days (3182)
Last 365 days (26274)
2026 (24105)
2025 (25763)
2024 (30039)
2023 (33983)
2022 (43332)
2021 (45746)
2020 (40896)
2019 (29854)
2018 (22486)
2017 (24201)
2016 (22674)
2015 (28887)
2014 (24886)
2013 (20697)
2012 (22506)
2011 (22769)
2010 (22436)
Location
Africa (346)
Alabama (101)
Alaska (3)
Arizona (378)
Arkansas (15)
Asia (29454)
Australia (4544)
California (15511)
Canada (4141)
China (1579)
Colorado (653)
Connecticut (609)
Delaware (419)
Europe (54872)
Florida (2263)
Georgia (465)
Hawaii (4)
Idaho (47)
Illinois (1070)
India (109)
Indiana (483)
Iowa (25)
Japan (644)
Kansas (122)
Kentucky (42)
Louisiana (46)
Maine (38)
Maryland (1611)
Massachusetts (11166)
Michigan (342)
Minnesota (705)
Mississippi (6)
Missouri (102)
Montana (32)
Nebraska (14)
Nevada (164)
New Hampshire (76)
New Jersey (3630)
New Mexico (19)
New York (3785)
North Carolina (1870)
North Dakota (11)
Northern California (8061)
Ohio (385)
Oklahoma (16)
Oregon (37)
Pennsylvania (2993)
Puerto Rico (28)
Rhode Island (43)
South America (530)
South Carolina (87)
South Dakota (1)
Southern California (6222)
Tennessee (166)
Texas (2519)
United States (52222)
Utah (456)
Vermont (1)
Virginia (277)
Washington D.C. (52)
Washington State (1228)
West Virginia (2)
Wisconsin (127)
Wyoming (2)
589,888 Results for "fate therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fate Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
November 5, 2026
·
22 min read
Press Releases
Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
October 1, 2026
·
1 min read
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - November 3, 2026
November 3, 2026
·
2 min read
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2026
October 4, 2026
·
2 min read
Press Releases
Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference
September 3, 2026
·
4 min read
Press Releases
Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
October 26, 2026
·
12 min read
Press Releases
Fate Therapeutics Presents New FT819 Data at ACR Convergence 2026 Highlighting Meaningful Clinical Responses in Lupus Without the Use of Conditioning Chemotherapy
November 10, 2026
·
16 min read
Press Releases
Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
August 13, 2026
·
23 min read
Press Releases
Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN
September 25, 2026
·
9 min read
Press Releases
Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies
October 12, 2026
·
7 min read
1 of 58,989
Next